Capital International Investors Merck & Co., Inc. Transaction History

Capital International Investors

$483 Billion
Q1 2024

A detailed history of Capital International Investors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital International Investors holds 6,023,853 shares of MRK stock, worth $756 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,023,853

Previous 157,905 3714.86%

Holding current value

$756 Million

Previous $17.2 Million 4517.45%

% of portfolio

0.16%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $664 Million - $774 Million	5,865,948 Added 3714.86%	6,023,853 $795 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $407,632 - $443,602	4,069 Added 2.65%	157,905 $17.2 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $21.1 Million - $23.4 Million	-204,968 Reduced 57.13%	153,836 $15.8 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $406,527 - $443,096	3,743 Added 1.05%	358,804 $41.4 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $62.8 Million - $70.1 Million	-609,954 Reduced 63.21%	355,061 $37.8 Million

Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $325,714 - $417,609	3,725 Added 0.39%	965,015 $107 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $196,447 - $220,687	2,324 Added 0.24%	961,290 $82.9 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $76.1 Million - $86.3 Million	-911,533 Reduced 48.73%	958,966 $87.6 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $1.1 Billion - $1.24 Billion	-15,017,143 Reduced 88.92%	1,870,499 $154 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $436 Million - $547 Million	-6,037,697 Reduced 26.34%	16,887,642 $1.29 Billion
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $429 Million - $472 Million	-5,990,137 Reduced 20.72%	22,925,339 $1.72 Billion
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $300 Million - $332 Million	-4,263,958 Reduced 12.85%	28,915,476 $2.25 Billion
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $101 Million - $119 Million	-1,471,214 Reduced 4.25%	33,179,434 $2.56 Billion
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $256 Million - $284 Million	-3,563,203 Reduced 9.32%	34,650,648 $2.83 Billion
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $159 Million - $180 Million	2,167,355 Added 6.01%	38,213,851 $3.17 Billion
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $576 Million - $655 Million	8,176,864 Added 29.34%	36,046,496 $2.79 Billion
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $745 Million - $1.03 Billion	-11,758,484 Reduced 29.67%	27,869,632 $2.14 Billion
Q4 2019 Feb 18, 2020	BUY	$77.58 - $87.54 $80.3 Million - $90.6 Million	1,034,782 Added 2.68%	39,628,116 $3.6 Billion
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $126 Million - $138 Million	1,659,465 Added 4.49%	38,593,334 $3.25 Billion
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $86.7 Million - $101 Million	1,240,883 Added 3.48%	36,933,869 $3.1 Billion
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $172 Million - $196 Million	2,475,569 Added 7.45%	35,692,986 $2.97 Billion
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $15.2 Million - $17.6 Million	232,811 Added 0.71%	33,217,417 $2.54 Billion
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $1.22 Billion - $1.43 Billion	21,127,887 Added 178.19%	32,984,606 $2.34 Billion
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $17,078 - $20,065	336 Added 0.0%	11,856,719 $720 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $32 Million - $37.2 Million	628,201 Added 5.59%	11,856,383 $646 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $82.8 Million - $98.9 Million	1,604,800 Added 16.68%	11,228,182 $632 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $565 Million - $608 Million	9,623,382	9,623,382 $616 Million

Others Institutions Holding MRK

# of Institutions

3,762

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $318B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Merck & Co., Inc. Transaction History